Galectin Therapeutics Inc (GALT) stock
GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.98+0.07 (+2.41%)
Close on Nov 18, 2026Market cap $300.53MP/E –Yield –
Galectin Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Galectin Therapeutics's market cap was $218.17M on Nov 11, 2026, against $369.43M a year earlier. Over the last 5 years it ranged from $67.15M to $372.19M, with a median of $123.01M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $218.17M | -18.7% |
| 2025 | Dec 31, 2025 | $268.21M | +233.7% |
| 2024 | Dec 31, 2024 | $80.38M | -21.7% |
| 2023 | Dec 29, 2023 | $102.67M | +52.9% |
| 2022 | Dec 30, 2022 | $67.15M | -45.3% |
| 2021 | Dec 31, 2021 | $122.84M | -3.9% |
| 2020 | Dec 31, 2020 | $127.85M | -21.1% |
| 2019 | Dec 31, 2019 | $162.04M | +14.8% |
| 2018 | Dec 31, 2018 | $141.10M | +18.5% |
| 2017 | Dec 29, 2017 | $119.03M | +313.3% |
| 2016 | Dec 30, 2016 | $28.80M | -26.6% |
| 2015 | Dec 31, 2015 | $39.24M | -48.9% |
| 2014 | Dec 31, 2014 | $76.77M | -46.2% |
| 2013 | Dec 31, 2013 | $142.62M | +335.7% |
| 2012 | Dec 31, 2012 | $32.73M | -55.7% |
| 2011 | Dec 30, 2011 | $73.83M | – |
See a number that looks wrong?